EIDX · Eidos Therapeutics
Acquired Company
BridgeBio completed its acquisition of all outstanding shares of Eidos Therapeutics, Inc. on January 26, 2021.
101 Montgomery St Ste 2550, California, 94104-4158, US
Pharmaceutical Preparation Manufacturing
Manufacturing
Market Cap
N/A
52 Wk Range
N/A - N/A
Previous Close
$122.21
Open
$122.21
Volume
N/A
Day Range
$122.21 - $122.21
Enterprise Value
N/A
Cash
N/A
Avg Qtr Burn
N/A
Insider Ownership
N/A
Institutional Own.
N/A
Qtr Updated
Jun 30th 2024